Global Doxorubicin Hydrochloride API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 123

Published Date: 16 Mar 2025

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Click To Send

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Doxorubicin Hydrochloride API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period. 
This report is a detailed and comprehensive analysis for global Doxorubicin Hydrochloride API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Doxorubicin Hydrochloride API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Doxorubicin Hydrochloride API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Doxorubicin Hydrochloride API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Doxorubicin Hydrochloride API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Doxorubicin Hydrochloride API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Doxorubicin Hydrochloride API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Intas Pharmaceuticals Ltd, Olon Spa, Sterling Biotech Ltd, Synbias Pharma Ag, Teva Pharmaceutical Industries Ltd, Meiji Seika Pharma Co Ltd, Microbiopharm Japan Co Ltd, Pharmacia And Upjohn Co, Boryung Pharmaceutical, Transo-Pharm Handels Gmbh, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Doxorubicin Hydrochloride API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Purity≥98%
    Purity

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Doxorubicin Hydrochloride API Consumption Value by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Purity≥98%

Table of Figures

List of Tables
 Table 1. Global Doxorubicin Hydrochloride API Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Doxorubicin Hydrochloride API Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Intas Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
 Table 4. Intas Pharmaceuticals Ltd Major Business
 Table 5. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Product and Services
 Table 6. Intas Pharmaceuticals Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 7. Intas Pharmaceuticals Ltd Recent Developments/Updates
 Table 8. Olon Spa Basic Information, Manufacturing Base and Competitors
 Table 9. Olon Spa Major Business
 Table 10. Olon Spa Doxorubicin Hydrochloride API Product and Services
 Table 11. Olon Spa Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 12. Olon Spa Recent Developments/Updates
 Table 13. Sterling Biotech Ltd Basic Information, Manufacturing Base and Competitors
 Table 14. Sterling Biotech Ltd Major Business
 Table 15. Sterling Biotech Ltd Doxorubicin Hydrochloride API Product and Services
 Table 16. Sterling Biotech Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 17. Sterling Biotech Ltd Recent Developments/Updates
 Table 18. Synbias Pharma Ag Basic Information, Manufacturing Base and Competitors
 Table 19. Synbias Pharma Ag Major Business
 Table 20. Synbias Pharma Ag Doxorubicin Hydrochloride API Product and Services
 Table 21. Synbias Pharma Ag Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 22. Synbias Pharma Ag Recent Developments/Updates
 Table 23. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
 Table 24. Teva Pharmaceutical Industries Ltd Major Business
 Table 25. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Product and Services
 Table 26. Teva Pharmaceutical Industries Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 27. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 28. Meiji Seika Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
 Table 29. Meiji Seika Pharma Co Ltd Major Business
 Table 30. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Product and Services
 Table 31. Meiji Seika Pharma Co Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 32. Meiji Seika Pharma Co Ltd Recent Developments/Updates
 Table 33. Microbiopharm Japan Co Ltd Basic Information, Manufacturing Base and Competitors
 Table 34. Microbiopharm Japan Co Ltd Major Business
 Table 35. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Product and Services
 Table 36. Microbiopharm Japan Co Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 37. Microbiopharm Japan Co Ltd Recent Developments/Updates
 Table 38. Pharmacia And Upjohn Co Basic Information, Manufacturing Base and Competitors
 Table 39. Pharmacia And Upjohn Co Major Business
 Table 40. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Product and Services
 Table 41. Pharmacia And Upjohn Co Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 42. Pharmacia And Upjohn Co Recent Developments/Updates
 Table 43. Boryung Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 44. Boryung Pharmaceutical Major Business
 Table 45. Boryung Pharmaceutical Doxorubicin Hydrochloride API Product and Services
 Table 46. Boryung Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 47. Boryung Pharmaceutical Recent Developments/Updates
 Table 48. Transo-Pharm Handels Gmbh Basic Information, Manufacturing Base and Competitors
 Table 49. Transo-Pharm Handels Gmbh Major Business
 Table 50. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Product and Services
 Table 51. Transo-Pharm Handels Gmbh Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 52. Transo-Pharm Handels Gmbh Recent Developments/Updates
 Table 53. Dzd Heze Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
 Table 54. Dzd Heze Pharmaceutical Co Ltd Major Business
 Table 55. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Product and Services
 Table 56. Dzd Heze Pharmaceutical Co Ltd Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 57. Dzd Heze Pharmaceutical Co Ltd Recent Developments/Updates
 Table 58. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 59. Zhejiang Hisun Pharmaceutical Major Business
 Table 60. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Product and Services
 Table 61. Zhejiang Hisun Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 62. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 63. Guangdong Lingnan Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 64. Guangdong Lingnan Pharmaceutical Major Business
 Table 65. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Product and Services
 Table 66. Guangdong Lingnan Pharmaceutical Doxorubicin Hydrochloride API Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 67. Guangdong Lingnan Pharmaceutical Recent Developments/Updates
 Table 68. Global Doxorubicin Hydrochloride API Sales Quantity by Manufacturer (2020-2025) & (Tons)
 Table 69. Global Doxorubicin Hydrochloride API Revenue by Manufacturer (2020-2025) & (USD Million)
 Table 70. Global Doxorubicin Hydrochloride API Average Price by Manufacturer (2020-2025) & (US$/Ton)
 Table 71. Market Position of Manufacturers in Doxorubicin Hydrochloride API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 72. Head Office and Doxorubicin Hydrochloride API Production Site of Key Manufacturer
 Table 73. Doxorubicin Hydrochloride API Market: Company Product Type Footprint
 Table 74. Doxorubicin Hydrochloride API Market: Company Product Application Footprint
 Table 75. Doxorubicin Hydrochloride API New Market Entrants and Barriers to Market Entry
 Table 76. Doxorubicin Hydrochloride API Mergers, Acquisition, Agreements, and Collaborations
 Table 77. Global Doxorubicin Hydrochloride API Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
 Table 78. Global Doxorubicin Hydrochloride API Sales Quantity by Region (2020-2025) & (Tons)
 Table 79. Global Doxorubicin Hydrochloride API Sales Quantity by Region (2026-2031) & (Tons)
 Table 80. Global Doxorubicin Hydrochloride API Consumption Value by Region (2020-2025) & (USD Million)
 Table 81. Global Doxorubicin Hydrochloride API Consumption Value by Region (2026-2031) & (USD Million)
 Table 82. Global Doxorubicin Hydrochloride API Average Price by Region (2020-2025) & (US$/Ton)
 Table 83. Global Doxorubicin Hydrochloride API Average Price by Region (2026-2031) & (US$/Ton)
 Table 84. Global Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 85. Global Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 86. Global Doxorubicin Hydrochloride API Consumption Value by Type (2020-2025) & (USD Million)
 Table 87. Global Doxorubicin Hydrochloride API Consumption Value by Type (2026-2031) & (USD Million)
 Table 88. Global Doxorubicin Hydrochloride API Average Price by Type (2020-2025) & (US$/Ton)
 Table 89. Global Doxorubicin Hydrochloride API Average Price by Type (2026-2031) & (US$/Ton)
 Table 90. Global Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 91. Global Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 92. Global Doxorubicin Hydrochloride API Consumption Value by Application (2020-2025) & (USD Million)
 Table 93. Global Doxorubicin Hydrochloride API Consumption Value by Application (2026-2031) & (USD Million)
 Table 94. Global Doxorubicin Hydrochloride API Average Price by Application (2020-2025) & (US$/Ton)
 Table 95. Global Doxorubicin Hydrochloride API Average Price by Application (2026-2031) & (US$/Ton)
 Table 96. North America Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 97. North America Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 98. North America Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 99. North America Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 100. North America Doxorubicin Hydrochloride API Sales Quantity by Country (2020-2025) & (Tons)
 Table 101. North America Doxorubicin Hydrochloride API Sales Quantity by Country (2026-2031) & (Tons)
 Table 102. North America Doxorubicin Hydrochloride API Consumption Value by Country (2020-2025) & (USD Million)
 Table 103. North America Doxorubicin Hydrochloride API Consumption Value by Country (2026-2031) & (USD Million)
 Table 104. Europe Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 105. Europe Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 106. Europe Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 107. Europe Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 108. Europe Doxorubicin Hydrochloride API Sales Quantity by Country (2020-2025) & (Tons)
 Table 109. Europe Doxorubicin Hydrochloride API Sales Quantity by Country (2026-2031) & (Tons)
 Table 110. Europe Doxorubicin Hydrochloride API Consumption Value by Country (2020-2025) & (USD Million)
 Table 111. Europe Doxorubicin Hydrochloride API Consumption Value by Country (2026-2031) & (USD Million)
 Table 112. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 113. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 114. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 115. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 116. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Region (2020-2025) & (Tons)
 Table 117. Asia-Pacific Doxorubicin Hydrochloride API Sales Quantity by Region (2026-2031) & (Tons)
 Table 118. Asia-Pacific Doxorubicin Hydrochloride API Consumption Value by Region (2020-2025) & (USD Million)
 Table 119. Asia-Pacific Doxorubicin Hydrochloride API Consumption Value by Region (2026-2031) & (USD Million)
 Table 120. South America Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 121. South America Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 122. South America Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 123. South America Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 124. South America Doxorubicin Hydrochloride API Sales Quantity by Country (2020-2025) & (Tons)
 Table 125. South America Doxorubicin Hydrochloride API Sales Quantity by Country (2026-2031) & (Tons)
 Table 126. South America Doxorubicin Hydrochloride API Consumption Value by Country (2020-2025) & (USD Million)
 Table 127. South America Doxorubicin Hydrochloride API Consumption Value by Country (2026-2031) & (USD Million)
 Table 128. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Type (2020-2025) & (Tons)
 Table 129. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Type (2026-2031) & (Tons)
 Table 130. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Application (2020-2025) & (Tons)
 Table 131. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Application (2026-2031) & (Tons)
 Table 132. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Country (2020-2025) & (Tons)
 Table 133. Middle East & Africa Doxorubicin Hydrochloride API Sales Quantity by Country (2026-2031) & (Tons)
 Table 134. Middle East & Africa Doxorubicin Hydrochloride API Consumption Value by Country (2020-2025) & (USD Million)
 Table 135. Middle East & Africa Doxorubicin Hydrochloride API Consumption Value by Country (2026-2031) & (USD Million)
 Table 136. Doxorubicin Hydrochloride API Raw Material
 Table 137. Key Manufacturers of Doxorubicin Hydrochloride API Raw Materials
 Table 138. Doxorubicin Hydrochloride API Typical Distributors
 Table 139. Doxorubicin Hydrochloride API Typical Customers


List of Figures
 Figure 1. Doxorubicin Hydrochloride API Picture
 Figure 2. Global Doxorubicin Hydrochloride API Revenue by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Doxorubicin Hydrochloride API Revenue Market Share by Type in 2024
 Figure 4. Purity≥98% Examples
 Figure 5. Purity

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Intas Pharmaceuticals Ltd
Olon Spa
Sterling Biotech Ltd
Synbias Pharma Ag
Teva Pharmaceutical Industries Ltd
Meiji Seika Pharma Co Ltd
Microbiopharm Japan Co Ltd
Pharmacia And Upjohn Co
Boryung Pharmaceutical
Transo-Pharm Handels Gmbh
Dzd Heze Pharmaceutical Co Ltd
Zhejiang Hisun Pharmaceutical
Guangdong Lingnan Pharmaceutical

Related Reports

Global Doxorubicin Hydrochloride API Supply, Demand and Key Producers, 2025-2031

Global Doxorubicin Hydrochloride API Supply, Demand and Key Producers, 2025-2031

date 30 Sep 2025

date Chemical & Material

The global Doxorubicin Hydrochloride API market size is expected to reach $ million by 2031, rising at a market growth of %CAGR during the forecast period (2025-2031).

Global Doxorubicin Hydrochloride API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Global Doxorubicin Hydrochloride API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

date 5 Feb 2026

date Chemical & Material

According to our (Global Info Research) latest study, the global Doxorubicin Hydrochloride API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.

Purchase Options

Single User License

USD3480.00

Multi Users License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords
artificial intelligence
electron
semiconductor
Battery
new energy
5G
AI
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.
Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.
Contact Us >>